236 related articles for article (PubMed ID: 6748234)
1. [Controversy on the treatment of early breast cancer].
Enomoto K; Ikeda T; Abe O
Gan No Rinsho; 1984 May; 30(6 Suppl):624-9. PubMed ID: 6748234
[TBL] [Abstract][Full Text] [Related]
2. Intraductal carcinoma of the breast.
von Rueden DG; Wilson RE
Surg Gynecol Obstet; 1984 Feb; 158(2):105-11. PubMed ID: 6320480
[TBL] [Abstract][Full Text] [Related]
3. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node dissection: does it have a role in primary breast cancer?
Pack MS; Thomas RS
Am Surg; 1996 Feb; 62(2):159-61. PubMed ID: 8554194
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
7. Incidence of intramammary nodes in completion mastectomy specimens after axillary node sampling: implications for breast conserving surgery.
Rampaul RS; Dale OT; Mitchell M; Blamey RW; Macmillan RD; Robertson JF; Ellis IO
Breast; 2008 Apr; 17(2):195-8. PubMed ID: 18164619
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
10. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.
Yu J; Li G; Li J; Wang Y
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):874-8. PubMed ID: 15708269
[TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node status of T1 primary breast cancer in a diverse population.
Madan AK; Macareo L; Winfrey K; Beech DJ
Am Surg; 2001 Jan; 67(1):71-4. PubMed ID: 11206902
[TBL] [Abstract][Full Text] [Related]
12. Axillary staging during surgery for breast cancer.
Axelsson CK; Mouridsen HT; Düring M; Møller S
Br J Surg; 2007 Mar; 94(3):304-9. PubMed ID: 17262756
[TBL] [Abstract][Full Text] [Related]
13. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
14. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
Petrik DW; McCready DR; Sawka CA; Goel V
J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
[TBL] [Abstract][Full Text] [Related]
16. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
17. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
[TBL] [Abstract][Full Text] [Related]
18. Axillary nodal metastasis of occult breast primary cancer.
Tamiolakis D; Antoniou C
Chirurgia (Bucur); 2008; 103(4):467-71. PubMed ID: 18780622
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic study of intramammary cancer residuals after outpatient excisional biopsy of breast cancer].
Yamashiro K; Miyakawa A; Kajiwara M; Ogita M; Sasaki M; Ichikawa T
Gan No Rinsho; 1986 Sep; 32(11):1395-9. PubMed ID: 3773267
[TBL] [Abstract][Full Text] [Related]
20. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial.
Christensen SB; Jansson C
Eur J Surg; 1993 Mar; 159(3):159-62. PubMed ID: 8102890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
